35 Results

People

  1. Shah
    Shah
  2. Lesokhin
    Lesokhin
  3. Mailankody
    Mailankody
  4. Giralt
    Giralt
  5. Hassoun
    Hassoun
  6. Korde
    Korde
  7. Landau
    Landau
  8. Chung
    Chung
  9. Shah
    Shah
  10. Scordo
    Scordo

Groups

  1. CTCR Scholars (35)
  2. Department of Medicine (35)
  3. Hematologic Malignancies, Division of (35)
  4. Center for Hematologic Malignancies (33)
  5. Survivorship Research (31)
  6. Myeloma (30)
  7. Bone Marrow Transplant (29)
  8. Hematologic Malignancies Research (29)
  9. Sloan Kettering Institute Postdocs (28)
  10. GME, Medicine (20)
  1. "Clinical Lymphoma, Myeloma and Leukemia"
  2. "CTCR Scholars"
Formats
  1. Meeting Abstract (34)
  2. Research Letter (1)
Groups
  1. CTCR Scholars (35)
  2. Department of Medicine (35)
  3. Hematologic Malignancies, Division of (35)
  4. Center for Hematologic Malignancies (33)
  5. Survivorship Research (31)
  6. Myeloma (30)

More Groups

People
  1. Urvi Shah (30)
  2. Alexander Lesokhin (29)
  3. Sham Mailankody (29)
  4. Hani Hassoun (28)
  5. Heather Landau (28)
  6. Malin Hultcrantz (28)

More People

Years
  1. 2023 (17)
  2. 2022 (8)
  3. 2021 (4)
  4. 2020 (1)
  5. 2019 (5)
Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (35)
Publishers
  1. Elsevier Inc. (35)

Results (35)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A whole foods plant-based weight loss intervention improves metabolic and immune biomarkers in MGUS/SMM patients as well as progression trajectory in a subset: The NUTRIVENTION trial
    Meeting Abstract

    Shah, U.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Hosszu, K.; Pollak, M.; Mailankody, S.; Korde, N.; Tan, C. R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Successful incorporation of ePRO using PROMIS-29 into standard of care after hematopoietic stem cell transplant and chimeric antigen receptor T cell therapy for plasma cell dyscrasias
    Meeting Abstract

    Shah, G.; Lobaugh, S.; Devlin, S.; Atkinson, T.; Korde, N.; Chung, D.; Dahi, P.; Landau, H.; Lahoud, O.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse national health and nutrition examination survey (NHANES) case-control study
    Meeting Abstract

    Joseph, J.; Tang, L.; Hillengass, J.; Landgren, O.; Usmani, S.; Lesokhin, A.; Moysich, K.; Shah, U.
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Clinical significance of baseline body mass index and its trajectory during triplet induction therapy in newly diagnosed multiple myeloma
    Meeting Abstract

    Thirugnanasambandam, R. P.; Firestone, R.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Mailankody, S.; Lahoud, O.; Landau, H.; Chung, D.; Shah, G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Whole genome sequencing reveals significant genetic admixture in multiple myeloma patients, impacting assessment of etiology
    Meeting Abstract

    Maclachlan, K.; Blaney, P.; Gagler, D.; Boyle, E.; Diamond, B.; Shah, U.; Korde, N.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Daratumumab, bortezomib, lenalidomide, and dexamethasone (DVRd) vs daratumumab, carfilzomib, lenalidomide and dexamethasone (DKRd) as induction therapy in newly diagnosed multiple myeloma
    Meeting Abstract

    Tan, C. R.; Maclachlan, K.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Patel, D.; Shekarkhand, T.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Ipilimumab after CD34-selected allogeneic stem cell transplantation (Allo HCT) for patients with relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Ghosh, A.; Nagel, K.; Hosszu, K.; Datta, A.; Thompson, C.; Levia, K.; Kamrowski, A.; McAvoy, D.; Chung, D.; Landau, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Evolving M-spike and risk of progression in smoldering multiple myeloma
    Meeting Abstract

    Hultcrantz, M.; Nemirovsky, D.; Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Patel, D.; Shah, U.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Adding Plinabulin to pegfilgrastim to shorten neutropenia and improve quality of life peri-autologous hematopoietic cell transplant for multiple myeloma
    Meeting Abstract

    Shah, G.; Hanley, D.; Datta, A.; Kamrowski, A.; Chung, D.; Gupta, G.; Hassoun, H.; Hoover, E.; Hultcrantz, M.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Evaluating dynamic changes in the serum free light chain ratio and its effect on risk of progression in smoldering multiple myeloma
    Meeting Abstract

    Akhlaghi, T.; Nemirovsky, D.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Patel, D.; Shah, U.; Tan, C. R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save